Yahoo Web Search

Search results

1. www.aaha.org › globalassets › 02-guidelines2018 AAHA Diabetes Management Guidelines for Dogs and Cats

   www.aaha.org › globalassets › 02-guidelines

   The initial approach to management of the diabetic cat is to ini-tiate insulin therapy with glargine (Lantus) or protamine zinc insulin (PZI; ProZinc) at a starting dose of 1 –2 units (U) per cat q 12 hr. The decision to monitor BG on the rst day of insulin treatment is. fi. at the discretion of the veterinarian.

2. pubmed.ncbi.nlm.nih.gov › 17508198Insulin glargine supplementation during early management ...

   pubmed.ncbi.nlm.nih.gov › 17508198

   Objective: To study the effect of subcutaneous administration of insulin glargine on the rate of resolution of acidosis and intravenous insulin infusion requirement in children with moderate and severe diabetic ketoacidosis (DKA). Study design: Retrospective cohort study. Setting: Pediatric intensive care unit of a university-based children's ...

3. www.ncbi.nlm.nih.gov › pmc › articlesDiabetic ketoacidosis: update on management - PMC

   www.ncbi.nlm.nih.gov › pmc › articles

   Key points. Diagnosis of diabetic ketoacidosis (DKA) is based on the biochemical triad of ketonaemia, hyperglycaemia, and acidaemia. Cornerstones of management are: fluid and potassium replacement; weight-based fixed rate intravenous insulin infusion (FRIII); and close biochemical monitoring of capillary ketones, serum electrolytes, venous pH ...

4. my.clevelandclinic.org › health › diseasesDiabetes-Related Ketoacidosis (DKA) - Cleveland Clinic

   my.clevelandclinic.org › health › diseases

   • Cached

   Oct 14, 2021 · Diabetes-Related Ketoacidosis (DKA) Diabetes-related ketoacidosis (DKA) is a life-threatening condition that affects people with diabetes and those who have undiagnosed diabetes. It happens when your body does not have enough insulin to use sugar for energy. Instead, your body breaks down fat for energy, which causes your body to release ketones.

5. www.medicalnewstoday.com › articles › 325973Lantus (insulin glargine): Side effects, dosage, cost, and more

   www.medicalnewstoday.com › articles › 325973

   • Cached

   Nov 17, 2022 · Note: Lantus isn’t approved to treat diabetic ketoacidosis (DKA), which is a possible complication of diabetes. For more information about DKA, see the “ Common questions about Lantus ...

6. www.med.unc.edu › emergmed › wp-contentDKA Guideline for Diagnosis HHS Guideline for Diagnosis

   www.med.unc.edu › emergmed › wp-content

   d. Add dextrose to fluids when glucose <200 for DKA or <300 for HHS IV. Potassium (K+) Replacement a. In renal insufficiency give 50% of normal dose i. Greater reductions in potassium dose may be necessary if patient is anuric b. When serum K+ < 3.3 mEq/L, place order and begin potassium replacement PRIOR to

7. www.drugs.com › tips › lantus-patient-tipsLantus: 7 things you should know - Drugs.com

   www.drugs.com › tips › lantus-patient-tips

   • Cached

   Feb 13, 2024 · The dosage of Lantus in elderly people should be conservative. Lantus must be given by subcutaneous (under the skin) injection. It should not be given by IV or IM injection or in an infusion pump. Lantus is not suitable for the treatment of diabetic ketoacidosis. Short-acting insulins should be used to treat this condition.